These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22962471)

  • 1. Identification of chemogenomic features from drug-target interaction networks using interpretable classifiers.
    Tabei Y; Pauwels E; Stoven V; Takemoto K; Yamanishi Y
    Bioinformatics; 2012 Sep; 28(18):i487-i494. PubMed ID: 22962471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug target prediction using adverse event report systems: a pharmacogenomic approach.
    Takarabe M; Kotera M; Nishimura Y; Goto S; Yamanishi Y
    Bioinformatics; 2012 Sep; 28(18):i611-i618. PubMed ID: 22962489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global optimization-based inference of chemogenomic features from drug-target interactions.
    Zu S; Chen T; Li S
    Bioinformatics; 2015 Aug; 31(15):2523-9. PubMed ID: 25819672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inferring Chemogenomic Features from Drug-Target Interaction Networks.
    Yamanishi Y
    Mol Inform; 2013 Dec; 32(11-12):991-9. PubMed ID: 27481144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relating drug-protein interaction network with drug side effects.
    Mizutani S; Pauwels E; Stoven V; Goto S; Yamanishi Y
    Bioinformatics; 2012 Sep; 28(18):i522-i528. PubMed ID: 22962476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inferring protein domains associated with drug side effects based on drug-target interaction network.
    Iwata H; Mizutani S; Tabei Y; Kotera M; Goto S; Yamanishi Y
    BMC Syst Biol; 2013; 7 Suppl 6(Suppl 6):S18. PubMed ID: 24565527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supervised prediction of drug-target interactions using bipartite local models.
    Bleakley K; Yamanishi Y
    Bioinformatics; 2009 Sep; 25(18):2397-403. PubMed ID: 19605421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of drug-target interaction networks from the integration of chemical and genomic spaces.
    Yamanishi Y; Araki M; Gutteridge A; Honda W; Kanehisa M
    Bioinformatics; 2008 Jul; 24(13):i232-40. PubMed ID: 18586719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-target interaction prediction from chemical, genomic and pharmacological data in an integrated framework.
    Yamanishi Y; Kotera M; Kanehisa M; Goto S
    Bioinformatics; 2010 Jun; 26(12):i246-54. PubMed ID: 20529913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying Drug-Target Interactions with Decision Templates.
    Yan XY; Zhang SW
    Curr Protein Pept Sci; 2018; 19(5):498-506. PubMed ID: 27829344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Network-based characterization of drug-protein interaction signatures with a space-efficient approach.
    Tabei Y; Kotera M; Sawada R; Yamanishi Y
    BMC Syst Biol; 2019 Apr; 13(Suppl 2):39. PubMed ID: 30953486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracting sets of chemical substructures and protein domains governing drug-target interactions.
    Yamanishi Y; Pauwels E; Saigo H; Stoven V
    J Chem Inf Model; 2011 May; 51(5):1183-94. PubMed ID: 21506615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectively Identifying Compound-Protein Interactions by Learning from Positive and Unlabeled Examples.
    Cheng Z; Zhou S; Wang Y; Liu H; Guan J; Chen YP
    IEEE/ACM Trans Comput Biol Bioinform; 2018; 15(6):1832-1843. PubMed ID: 28113437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancing the accuracy of chemogenomic models with a three-dimensional binding site kernel.
    Meslamani J; Rognan D
    J Chem Inf Model; 2011 Jul; 51(7):1593-603. PubMed ID: 21644501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovering patterns in drug-protein interactions based on their fingerprints.
    Luo W; Chan KC
    BMC Bioinformatics; 2012 Jun; 13 Suppl 9(Suppl 9):S4. PubMed ID: 22901089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linear and Kernel Model Construction Methods for Predicting Drug-Target Interactions in a Chemogenomic Framework.
    Yamanishi Y
    Methods Mol Biol; 2018; 1825():355-368. PubMed ID: 30334213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sparse Modeling to Analyze Drug-Target Interaction Networks.
    Yamanishi Y
    Methods Mol Biol; 2018; 1807():181-193. PubMed ID: 30030811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational probing protein-protein interactions targeting small molecules.
    Wang YC; Chen SL; Deng NY; Wang Y
    Bioinformatics; 2016 Jan; 32(2):226-34. PubMed ID: 26415726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gaussian interaction profile kernels for predicting drug-target interaction.
    van Laarhoven T; Nabuurs SB; Marchiori E
    Bioinformatics; 2011 Nov; 27(21):3036-43. PubMed ID: 21893517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting target-ligand interactions using protein ligand-binding site and ligand substructures.
    Wang C; Liu J; Luo F; Deng Z; Hu QN
    BMC Syst Biol; 2015; 9 Suppl 1(Suppl 1):S2. PubMed ID: 25707321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.